October 3, 2025BMC Complementary Medicine and TherapiesOpen Access

Effectiveness and safety analysis of Qifu Yixin Prescription for the treatment of heart failure with preserved ejection fraction: study protocol for a randomized, double-blind, placebo-controlled clinical trial

View Full Paper

Ask AI

Bookmark

The study measures clinical effectiveness of Qifu Yixin Prescription in improving heart failure outcomes and overall patient health.
Primary outcome includes change in NYHA classification at 24 weeks, demonstrating effectiveness measures over time.
Randomized controlled trial design ensures reliability, facilitating comparison between the Qifu Yixin group and placebo.
Safety evaluations will monitor multiple health indicators, helping to assess any adverse effects during the treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized controlled trial assesses clinical effectiveness and safety of Qifu Yixin Prescription in heart failure, suggesting potential new treatment options.

Cite This Study

Xu et al. (2025) studied this question.

synapsesocial.com/papers/68dfe93cdaa1363beb049fee https://doi.org/10.1186/s12906-025-05106-3

View Full Paper

Ask AI

Bookmark

Implication

Randomized controlled trial assesses clinical effectiveness and safety of Qifu Yixin Prescription in heart failure, suggesting potential new treatment options.

Effectiveness and safety analysis of Qifu Yixin Prescription for the treatment of heart failure with preserved ejection fraction: study protocol for a randomized, double-blind, placebo-controlled clinical trial

Key Points

Discussion

Implication

Cite This Study

Effectiveness and safety analysis of Qifu Yixin Prescription for the treatment of heart failure with preserved ejection fraction: study protocol for a randomized, double-blind, placebo-controlled clinical trial

Key Points

Discussion

Implication

Cite This Study